Antisense therapeutics are used to treat conditions like Duchenne muscular dystrophy (DMD), spinal muscular atrophy (SMA), and hereditary transthyretin-mediated amyloidosis (hATTR). They also have other uses, such as treating amyotrophic lateral sclerosis (ALS). These medications work by altering specific genetic instructions to impact the production of certain proteins in the body. Antisense therapeutics come as different injectable options. Examples include Exondys 51 (eteplirsen), Spinraza (nusinersen), and Tegsedi (inotersen).